TBIO — Telesis Bio Share News
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
- $0.07m
- $1.97m
- $27.51m
Codex DNA Inc reports results for the quarter ended in June - Earnings Summary
Brief: Codex DNA Posts Q2 Loss Per Share Of $1.06
Translate Bio Inc reports results for the quarter ended in June - Earnings Summary
Brief: Translate Bio Reports Q2 2021 Financial Results
Brief: Codex DNA Announces Synthetic Biology Collaboration With U.S. Department Of Agriculture To Combat Citrus Greening Disease
Analysis: Sanofi's COVID-19 vaccine setback, drug pipeline cast long shadow
Press Digest: Financial Times - Aug. 4
US STOCKS-S&P 500 closes at record high as Apple, healthcare stocks help shrug off Delta worries
US STOCKS-S&P closes at record high as Apple, healthcare stocks help shrug off Delta worries
US STOCKS-Apple, healthcare stocks help Wall St shrug off Delta worries
U.S. STOCKS ON THE MOVE-Willis Towers, Eli Lilly, Clorox, SolarEdge
mRNA cos up after Sanofi snaps up Translate Bio in $3.2 bln deal
U.S. STOCKS ON THE MOVE-BP Plc, Boise Cascade, Simon Property, NetEase
Translate Bio surges on $3.2 bln buyout deal with Sanofi
Sanofi M&A punt soothes France’s Covid-19 shame
-Sanofi agrees to buy U.S. mRNA partner Translate Bio in $3.2 bln deal (updated)
Sanofi makes $3.2 bln offer for U.S. mRNA partner Translate Bio
Sanofi confirms $3.2 bln offer to buy U.S. biotech firm Translate Bio
Translate Bio rises after Reuters report on Sanofi's buyout offer